Enrollment in Protocol 93-04-11
Item
Patient must have been previously enrolled in Protocol 93-04-11 and randomized to the placebo arm; or the patient met all eligibility criteria for protocol 93-04-11 other than the expression of CD25 on CTCL tumor cells.
boolean
Disease stage
Item
CTCL disease Stage Ia - III
boolean
Previous therapy
Item
History of less than or equal to 3 previous therapies. Repeated use of the same agent is considered to be 1 therapy unless it is part of a different combination regimen. Only 1 prior combination cytotoxic chemotherapy regimen is permitted. Topical or systemic steroids are not considered a therapy
boolean
Disease characteristics
Item
Patient must have evaluable or measurable disease. Lymph node involvement no greater than LN2. No CTCL involvement of bone marrow.
boolean
Other diseases
Item
No significant pulmonary or cardiac disease. No active CNS, kidney, or liver disease. No systemic infections.
boolean
ECOG
Item
ECOG performance status of 0 or 1
boolean
Other protocols
Item
The 93-04-14 study is no longer open to subjects previously enrolled in 93-04-10 or 92-04-01
boolean
Enrollment
Item
Enrollment
string
C1516879 (UMLS CUI)
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
Diagnostic Neoplasm Staging
Item
Diagnostic Neoplasm Staging
string
C0027646 (UMLS CUI)
Therapeutic procedure
Item
Therapeutic procedure
string
C0087111 (UMLS CUI)
Pharmaceutical Preparations
Item
Pharmaceutical Preparations
string
C0013227 (UMLS CUI)
ECOG performance status finding
Item
ECOG performance status finding
string
C1828127 (UMLS CUI)
424122007 (SNOMED CT 2010_0731)